Invesco Ltd.

SEC CIK: 0000914208
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

MNPR holding history

Monopar Therapeutics in every 13F filed by Invesco Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MNPR overview All 13F holders of MNPR Full Q2 2026 holdings

Shares (Q2 2026): 2,356
Value: $218.1K
% of portfolio: <0.1%
Quarters held: 2; Since Q4 2025

Holdings of MNPR by Invesco Ltd., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	2,356	$218.1K	<0.1%	+2,356	New	Holders
Q1 2026	0	$0	0.0%	−3,355−100.0%	Sold out	Holders
Q4 2025	3,355	$219.1K	<0.1%	+3,355	New	Holders